Effects of Parenteral Nutrition With Different Lipid Emulsions in Preterm Infants

NCT01683162 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2012-09-18

No results posted yet for this study

Summary

Previous studies have suggested that olive oil-based emulsion is safe and well tolerated in preterm infants, a showed efficacy and a good clinical and biological safety profile. The objective of this study was to assess the effects of a new olive-oil based lipid emulsion compared with the traditional lipid emulsions.

Conditions

  • Preterm Infant

Interventions

DRUG

ClinOleic

the lipid of all-in-one, 0.5-3.5g/kg.d

DRUG

Lipofundin

the lipid of all-in-one, 0.5-3.5g/kg.d

DRUG

Intralipid

the lipid of all-in-one, 0.5-3.5g/kg.d

Sponsors & Collaborators

  • Wei Cai

    lead OTHER

Principal Investigators

  • Ying Wang, phd · Xin Hua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai,China

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2012-12-31
Completion
2013-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01683162 on ClinicalTrials.gov